Global Kidney Fibrosis Treatment Market Research Report 2025

Industry: Medical Care

Published: 2025-02-27

Pages: 71 Pages

Report ld: 4342857

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global market for Kidney Fibrosis Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Kidney Fibrosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Fibrosis Treatment.

The Kidney Fibrosis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Kidney Fibrosis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Kidney Fibrosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Report Metric
Details
Report Title
Global Kidney Fibrosis Treatment Market Research Report 2025
Market Size Available for Years
2025-2031
Global Kidney Fibrosis Treatment Companies Covered
Merck and Co
Pfizer Inc
F. Hoffman-La Roche(Switzerland)
InterMune Inc
Galectin Therapeutics
La Jolla Pharmaceutical Company
ProMetic Life-Sciences Inc(Canada)
BioLine Rx(Israel)
Genzyme Corporation
Global Kidney Fibrosis Treatment Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Kidney Fibrosis Treatment Market, Segment by Type
Angiotensin Converting Enzyme (ACE) Inhibitors
Pirfenidone
Renin Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Vasopeptidase Inhibitors
Global Kidney Fibrosis Treatment Market, Segment by Application
Chronic Kidney Diseases
Kidney Cancer Treatment
Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Kidney Fibrosis Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Kidney Fibrosis Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
        1.2.2 Angiotensin Converting Enzyme (ACE) Inhibitors
        1.2.3 Pirfenidone
        1.2.4 Renin Inhibitors
        1.2.5 Angiotensin II Receptor Blockers (ARBs)
        1.2.6 Vasopeptidase Inhibitors
    1.3 Market by Application
        1.3.1 Global Kidney Fibrosis Treatment Market Growth by Application: 2020 VS 2024 VS 2031
        1.3.2 Chronic Kidney Diseases
        1.3.3 Kidney Cancer Treatment
        1.3.4 Others
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Global Growth Trends
    2.1 Global Kidney Fibrosis Treatment Market Perspective (2020-2031)
    2.2 Global Kidney Fibrosis Treatment Growth Trends by Region
        2.2.1 Global Kidney Fibrosis Treatment Market Size by Region: 2020 VS 2024 VS 2031
        2.2.2 Kidney Fibrosis Treatment Historic Market Size by Region (2020-2025)
        2.2.3 Kidney Fibrosis Treatment Forecasted Market Size by Region (2026-2031)
    2.3 Kidney Fibrosis Treatment Market Dynamics
        2.3.1 Kidney Fibrosis Treatment Industry Trends
        2.3.2 Kidney Fibrosis Treatment Market Drivers
        2.3.3 Kidney Fibrosis Treatment Market Challenges
        2.3.4 Kidney Fibrosis Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Kidney Fibrosis Treatment Players by Revenue
        3.1.1 Global Top Kidney Fibrosis Treatment Players by Revenue (2020-2025)
        3.1.2 Global Kidney Fibrosis Treatment Revenue Market Share by Players (2020-2025)
    3.2 Global Kidney Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Global Key Players Ranking by Kidney Fibrosis Treatment Revenue
    3.4 Global Kidney Fibrosis Treatment Market Concentration Ratio
        3.4.1 Global Kidney Fibrosis Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Kidney Fibrosis Treatment Revenue in 2024
    3.5 Global Key Players of Kidney Fibrosis Treatment Head office and Area Served
    3.6 Global Key Players of Kidney Fibrosis Treatment, Product and Application
    3.7 Global Key Players of Kidney Fibrosis Treatment, Date of Enter into This Industry
    3.8 Mergers & Acquisitions, Expansion Plans

4 Kidney Fibrosis Treatment Breakdown Data by Type
    4.1 Global Kidney Fibrosis Treatment Historic Market Size by Type (2020-2025)
    4.2 Global Kidney Fibrosis Treatment Forecasted Market Size by Type (2026-2031)

5 Kidney Fibrosis Treatment Breakdown Data by Application
    5.1 Global Kidney Fibrosis Treatment Historic Market Size by Application (2020-2025)
    5.2 Global Kidney Fibrosis Treatment Forecasted Market Size by Application (2026-2031)

6 North America
    6.1 North America Kidney Fibrosis Treatment Market Size (2020-2031)
    6.2 North America Kidney Fibrosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
    6.3 North America Kidney Fibrosis Treatment Market Size by Country (2020-2025)
    6.4 North America Kidney Fibrosis Treatment Market Size by Country (2026-2031)
    6.5 United States
    6.6 Canada

7 Europe
    7.1 Europe Kidney Fibrosis Treatment Market Size (2020-2031)
    7.2 Europe Kidney Fibrosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
    7.3 Europe Kidney Fibrosis Treatment Market Size by Country (2020-2025)
    7.4 Europe Kidney Fibrosis Treatment Market Size by Country (2026-2031)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

8 Asia-Pacific
    8.1 Asia-Pacific Kidney Fibrosis Treatment Market Size (2020-2031)
    8.2 Asia-Pacific Kidney Fibrosis Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
    8.3 Asia-Pacific Kidney Fibrosis Treatment Market Size by Region (2020-2025)
    8.4 Asia-Pacific Kidney Fibrosis Treatment Market Size by Region (2026-2031)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

9 Latin America
    9.1 Latin America Kidney Fibrosis Treatment Market Size (2020-2031)
    9.2 Latin America Kidney Fibrosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
    9.3 Latin America Kidney Fibrosis Treatment Market Size by Country (2020-2025)
    9.4 Latin America Kidney Fibrosis Treatment Market Size by Country (2026-2031)
    9.5 Mexico
    9.6 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Kidney Fibrosis Treatment Market Size (2020-2031)
    10.2 Middle East & Africa Kidney Fibrosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
    10.3 Middle East & Africa Kidney Fibrosis Treatment Market Size by Country (2020-2025)
    10.4 Middle East & Africa Kidney Fibrosis Treatment Market Size by Country (2026-2031)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

11 Key Players Profiles
    11.1 Merck and Co
        11.1.1 Merck and Co Company Details
        11.1.2 Merck and Co Business Overview
        11.1.3 Merck and Co Kidney Fibrosis Treatment Introduction
        11.1.4 Merck and Co Revenue in Kidney Fibrosis Treatment Business (2020-2025)
        11.1.5 Merck and Co Recent Development
    11.2 Pfizer Inc
        11.2.1 Pfizer Inc Company Details
        11.2.2 Pfizer Inc Business Overview
        11.2.3 Pfizer Inc Kidney Fibrosis Treatment Introduction
        11.2.4 Pfizer Inc Revenue in Kidney Fibrosis Treatment Business (2020-2025)
        11.2.5 Pfizer Inc Recent Development
    11.3 F. Hoffman-La Roche(Switzerland)
        11.3.1 F. Hoffman-La Roche(Switzerland) Company Details
        11.3.2 F. Hoffman-La Roche(Switzerland) Business Overview
        11.3.3 F. Hoffman-La Roche(Switzerland) Kidney Fibrosis Treatment Introduction
        11.3.4 F. Hoffman-La Roche(Switzerland) Revenue in Kidney Fibrosis Treatment Business (2020-2025)
        11.3.5 F. Hoffman-La Roche(Switzerland) Recent Development
    11.4 InterMune Inc
        11.4.1 InterMune Inc Company Details
        11.4.2 InterMune Inc Business Overview
        11.4.3 InterMune Inc Kidney Fibrosis Treatment Introduction
        11.4.4 InterMune Inc Revenue in Kidney Fibrosis Treatment Business (2020-2025)
        11.4.5 InterMune Inc Recent Development
    11.5 Galectin Therapeutics
        11.5.1 Galectin Therapeutics Company Details
        11.5.2 Galectin Therapeutics Business Overview
        11.5.3 Galectin Therapeutics Kidney Fibrosis Treatment Introduction
        11.5.4 Galectin Therapeutics Revenue in Kidney Fibrosis Treatment Business (2020-2025)
        11.5.5 Galectin Therapeutics Recent Development
    11.6 La Jolla Pharmaceutical Company
        11.6.1 La Jolla Pharmaceutical Company Company Details
        11.6.2 La Jolla Pharmaceutical Company Business Overview
        11.6.3 La Jolla Pharmaceutical Company Kidney Fibrosis Treatment Introduction
        11.6.4 La Jolla Pharmaceutical Company Revenue in Kidney Fibrosis Treatment Business (2020-2025)
        11.6.5 La Jolla Pharmaceutical Company Recent Development
    11.7 ProMetic Life-Sciences Inc(Canada)
        11.7.1 ProMetic Life-Sciences Inc(Canada) Company Details
        11.7.2 ProMetic Life-Sciences Inc(Canada) Business Overview
        11.7.3 ProMetic Life-Sciences Inc(Canada) Kidney Fibrosis Treatment Introduction
        11.7.4 ProMetic Life-Sciences Inc(Canada) Revenue in Kidney Fibrosis Treatment Business (2020-2025)
        11.7.5 ProMetic Life-Sciences Inc(Canada) Recent Development
    11.8 BioLine Rx(Israel)
        11.8.1 BioLine Rx(Israel) Company Details
        11.8.2 BioLine Rx(Israel) Business Overview
        11.8.3 BioLine Rx(Israel) Kidney Fibrosis Treatment Introduction
        11.8.4 BioLine Rx(Israel) Revenue in Kidney Fibrosis Treatment Business (2020-2025)
        11.8.5 BioLine Rx(Israel) Recent Development
    11.9 Genzyme Corporation
        11.9.1 Genzyme Corporation Company Details
        11.9.2 Genzyme Corporation Business Overview
        11.9.3 Genzyme Corporation Kidney Fibrosis Treatment Introduction
        11.9.4 Genzyme Corporation Revenue in Kidney Fibrosis Treatment Business (2020-2025)
        11.9.5 Genzyme Corporation Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
            13.1.1.1 Research Programs/Design
            13.1.1.2 Market Size Estimation
            13.1.1.3 Market Breakdown and Data Triangulation
        13.1.2 Data Source
            13.1.2.1 Secondary Sources
            13.1.2.2 Primary Sources
    13.2 Author Details
    13.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Kidney Fibrosis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Angiotensin Converting Enzyme (ACE) Inhibitors
 Table 3. Key Players of Pirfenidone
 Table 4. Key Players of Renin Inhibitors
 Table 5. Key Players of Angiotensin II Receptor Blockers (ARBs)
 Table 6. Key Players of Vasopeptidase Inhibitors
 Table 7. Global Kidney Fibrosis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Kidney Fibrosis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Kidney Fibrosis Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Kidney Fibrosis Treatment Market Share by Region (2020-2025)
 Table 11. Global Kidney Fibrosis Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Kidney Fibrosis Treatment Market Share by Region (2026-2031)
 Table 13. Kidney Fibrosis Treatment Market Trends
 Table 14. Kidney Fibrosis Treatment Market Drivers
 Table 15. Kidney Fibrosis Treatment Market Challenges
 Table 16. Kidney Fibrosis Treatment Market Restraints
 Table 17. Global Kidney Fibrosis Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Kidney Fibrosis Treatment Market Share by Players (2020-2025)
 Table 19. Global Top Kidney Fibrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Fibrosis Treatment as of 2024)
 Table 20. Ranking of Global Top Kidney Fibrosis Treatment Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Kidney Fibrosis Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Kidney Fibrosis Treatment, Headquarters and Area Served
 Table 23. Global Key Players of Kidney Fibrosis Treatment, Product and Application
 Table 24. Global Key Players of Kidney Fibrosis Treatment, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Kidney Fibrosis Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Kidney Fibrosis Treatment Revenue Market Share by Type (2020-2025)
 Table 28. Global Kidney Fibrosis Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Kidney Fibrosis Treatment Revenue Market Share by Type (2026-2031)
 Table 30. Global Kidney Fibrosis Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Kidney Fibrosis Treatment Revenue Market Share by Application (2020-2025)
 Table 32. Global Kidney Fibrosis Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Kidney Fibrosis Treatment Revenue Market Share by Application (2026-2031)
 Table 34. North America Kidney Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Kidney Fibrosis Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Kidney Fibrosis Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Kidney Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Kidney Fibrosis Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Kidney Fibrosis Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Kidney Fibrosis Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Kidney Fibrosis Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Kidney Fibrosis Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Kidney Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Kidney Fibrosis Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Kidney Fibrosis Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Kidney Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Kidney Fibrosis Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Kidney Fibrosis Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Merck and Co Company Details
 Table 50. Merck and Co Business Overview
 Table 51. Merck and Co Kidney Fibrosis Treatment Product
 Table 52. Merck and Co Revenue in Kidney Fibrosis Treatment Business (2020-2025) & (US$ Million)
 Table 53. Merck and Co Recent Development
 Table 54. Pfizer Inc Company Details
 Table 55. Pfizer Inc Business Overview
 Table 56. Pfizer Inc Kidney Fibrosis Treatment Product
 Table 57. Pfizer Inc Revenue in Kidney Fibrosis Treatment Business (2020-2025) & (US$ Million)
 Table 58. Pfizer Inc Recent Development
 Table 59. F. Hoffman-La Roche(Switzerland) Company Details
 Table 60. F. Hoffman-La Roche(Switzerland) Business Overview
 Table 61. F. Hoffman-La Roche(Switzerland) Kidney Fibrosis Treatment Product
 Table 62. F. Hoffman-La Roche(Switzerland) Revenue in Kidney Fibrosis Treatment Business (2020-2025) & (US$ Million)
 Table 63. F. Hoffman-La Roche(Switzerland) Recent Development
 Table 64. InterMune Inc Company Details
 Table 65. InterMune Inc Business Overview
 Table 66. InterMune Inc Kidney Fibrosis Treatment Product
 Table 67. InterMune Inc Revenue in Kidney Fibrosis Treatment Business (2020-2025) & (US$ Million)
 Table 68. InterMune Inc Recent Development
 Table 69. Galectin Therapeutics Company Details
 Table 70. Galectin Therapeutics Business Overview
 Table 71. Galectin Therapeutics Kidney Fibrosis Treatment Product
 Table 72. Galectin Therapeutics Revenue in Kidney Fibrosis Treatment Business (2020-2025) & (US$ Million)
 Table 73. Galectin Therapeutics Recent Development
 Table 74. La Jolla Pharmaceutical Company Company Details
 Table 75. La Jolla Pharmaceutical Company Business Overview
 Table 76. La Jolla Pharmaceutical Company Kidney Fibrosis Treatment Product
 Table 77. La Jolla Pharmaceutical Company Revenue in Kidney Fibrosis Treatment Business (2020-2025) & (US$ Million)
 Table 78. La Jolla Pharmaceutical Company Recent Development
 Table 79. ProMetic Life-Sciences Inc(Canada) Company Details
 Table 80. ProMetic Life-Sciences Inc(Canada) Business Overview
 Table 81. ProMetic Life-Sciences Inc(Canada) Kidney Fibrosis Treatment Product
 Table 82. ProMetic Life-Sciences Inc(Canada) Revenue in Kidney Fibrosis Treatment Business (2020-2025) & (US$ Million)
 Table 83. ProMetic Life-Sciences Inc(Canada) Recent Development
 Table 84. BioLine Rx(Israel) Company Details
 Table 85. BioLine Rx(Israel) Business Overview
 Table 86. BioLine Rx(Israel) Kidney Fibrosis Treatment Product
 Table 87. BioLine Rx(Israel) Revenue in Kidney Fibrosis Treatment Business (2020-2025) & (US$ Million)
 Table 88. BioLine Rx(Israel) Recent Development
 Table 89. Genzyme Corporation Company Details
 Table 90. Genzyme Corporation Business Overview
 Table 91. Genzyme Corporation Kidney Fibrosis Treatment Product
 Table 92. Genzyme Corporation Revenue in Kidney Fibrosis Treatment Business (2020-2025) & (US$ Million)
 Table 93. Genzyme Corporation Recent Development
 Table 94. Research Programs/Design for This Report
 Table 95. Key Data Information from Secondary Sources
 Table 96. Key Data Information from Primary Sources
 Table 97. Authors List of This Report


List of Figures
 Figure 1. Kidney Fibrosis Treatment Picture
 Figure 2. Global Kidney Fibrosis Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Kidney Fibrosis Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Angiotensin Converting Enzyme (ACE) Inhibitors Features
 Figure 5. Pirfenidone Features
 Figure 6. Renin Inhibitors Features
 Figure 7. Angiotensin II Receptor Blockers (ARBs) Features
 Figure 8. Vasopeptidase Inhibitors Features
 Figure 9. Global Kidney Fibrosis Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Kidney Fibrosis Treatment Market Share by Application: 2024 VS 2031
 Figure 11. Chronic Kidney Diseases Case Studies
 Figure 12. Kidney Cancer Treatment Case Studies
 Figure 13. Others Case Studies
 Figure 14. Kidney Fibrosis Treatment Report Years Considered
 Figure 15. Global Kidney Fibrosis Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Kidney Fibrosis Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Kidney Fibrosis Treatment Market Share by Region: 2024 VS 2031
 Figure 18. Global Kidney Fibrosis Treatment Market Share by Players in 2024
 Figure 19. Global Top Kidney Fibrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Fibrosis Treatment as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Kidney Fibrosis Treatment Revenue in 2024
 Figure 21. North America Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Kidney Fibrosis Treatment Market Share by Country (2020-2031)
 Figure 23. United States Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Kidney Fibrosis Treatment Market Share by Country (2020-2031)
 Figure 27. Germany Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Kidney Fibrosis Treatment Market Share by Region (2020-2031)
 Figure 35. China Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Kidney Fibrosis Treatment Market Share by Country (2020-2031)
 Figure 43. Mexico Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Kidney Fibrosis Treatment Market Share by Country (2020-2031)
 Figure 47. Turkey Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Kidney Fibrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Merck and Co Revenue Growth Rate in Kidney Fibrosis Treatment Business (2020-2025)
 Figure 51. Pfizer Inc Revenue Growth Rate in Kidney Fibrosis Treatment Business (2020-2025)
 Figure 52. F. Hoffman-La Roche(Switzerland) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2020-2025)
 Figure 53. InterMune Inc Revenue Growth Rate in Kidney Fibrosis Treatment Business (2020-2025)
 Figure 54. Galectin Therapeutics Revenue Growth Rate in Kidney Fibrosis Treatment Business (2020-2025)
 Figure 55. La Jolla Pharmaceutical Company Revenue Growth Rate in Kidney Fibrosis Treatment Business (2020-2025)
 Figure 56. ProMetic Life-Sciences Inc(Canada) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2020-2025)
 Figure 57. BioLine Rx(Israel) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2020-2025)
 Figure 58. Genzyme Corporation Revenue Growth Rate in Kidney Fibrosis Treatment Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed

Description

The global market for Kidney Fibrosis Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Kidney Fibrosis Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Related Reports

Global Kidney Fibrosis Treatment Market Research Report 2023
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2023-06-11
Pages: 85
USD 2900.00
(Single User License)
Global Kidney Fibrosis Treatment Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2023-05-30
Pages: 102
USD 5600.00
(Single User License)
Global Kidney Fibrosis Treatment Market Insights, Forecast to 2029
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2023-05-31
Pages: 91
USD 4900.00
(Single User License)
Global Kidney Fibrosis Treatment Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2023-05-30
Pages: 88
USD 3350.00
(Single User License)
Global Kidney Fibrosis Treatment Market Research Report 2024
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2024-01-04
Pages: 78
USD 2900.00
(Single User License)
Kidney Fibrosis Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2024-01-24
Pages: 92
USD 3950.00
(Single User License)
Global Kidney Fibrosis Treatment Market Insights, Forecast to 2030
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2024-04-28
Pages: 88
USD 4900.00
(Single User License)
Kidney Fibrosis Treatment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Kidney Fibrosis Treatment was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 89
USD 3950.00
(Single User License)